ASH 2021 Updates: MDS and Secondary AML @AAMDSIF

Uploaded January 2025 | Updated September 2026, 7 hours ago

In this webinar, Dr. Elizabeth Griffiths discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2021 meeting in Atlanta, GA. Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation.

Genetics and Genomics with Dr. Daria Babushok and Dr. Marcin Wlodarski

Transplantation for Bone Marrow Failure with Dr. Amy DeZern and Dr. Michael Pulsipher

PNH Non-Transplant Therapies, from the 2023 3-City Tandem Patient and Family Conferences

Ask the PNH Expert, Thomas Deloughery, MD - 2022 Webinars

High Risk MDS Session Summary with Hetty Carraway

Management of Aplastic Anemia - San Antonio P&FVC

Transplant for MDS, or Myelodysplastic Syndromes from the Patient and Family Conference, Utah, 2023

Ask the Pediatric Expert - Q and A with Dr. Joseph Oved